{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:23:18Z","timestamp":1782444198770,"version":"3.54.5"},"reference-count":16,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Newborn screening (NBS) has widely been utilized in developed countries as a cost-effective public health strategy that reduces morbidity and mortality. Developing countries, however, are new to the NBS scene and have their own unique challenges, both in instituting the program as well as effectively acting on the results. NBS offers numerous ethical issues on a global scale, however, here we argue that there are unique ethical issues surrounding the development and expansion of newborn screening in Latin America given its highly heterogenous population. Once a NBS program is effectively instated, ethical considerations continue when pursuing expansion of screening to include further conditions. While Latin America grapples with the ethics of expanded newborn screening (ENBS), some developed countries discuss utility of genomic sequencing technologies in the newborn population. When the ability to detect further pathology is expanded, one must know what to do with this information. As rare diseases are identified either on ENBS or via genome sequencing, access to treatments for these rare diseases can be a real challenge. If we consider newborn screening as a global initiative, then we need more than a deontology approach to analyze these challenges; we need an approach that considers the unique characteristics of each territory and tremendous heterogeneity that exists prior to the implementation of these programs. As genomic technology advances further in the developed world, while some developing countries still lack even basic newborn screening, there is a further widening of the gap in global health disparities. The question is posed as to who has responsibility for these newborns\u2019 lives on an international level. Without an approach towards newborn screening that accounts for the diverse global population, we believe optimal outcomes for newborns and families across the world will not be achieved.<\/jats:p>","DOI":"10.3390\/ijns7010006","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T09:49:21Z","timestamp":1611222561000},"page":"6","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Expanded Newborn Screening and Genomic Sequencing in Latin America and the Resulting Social Justice and Ethical Considerations"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6103-9724","authenticated-orcid":false,"given":"Juan","family":"Cabello","sequence":"first","affiliation":[{"name":"Instituto de Nutrici\u00f3n y Tecnolog\u00eda de los Alimentos (INTA), University of Chile, Santiago 7830489, Chile"},{"name":"Pediatric Neurology Fellowship Program, University of Valpara\u00edso, Valparaiso 2341131, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Novoa","sequence":"additional","affiliation":[{"name":"Pediatric Neurology Fellowship Program, University of Valpara\u00edso, Valparaiso 2341131, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanalise","family":"Huff","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Colombo","sequence":"additional","affiliation":[{"name":"Instituto de Nutrici\u00f3n y Tecnolog\u00eda de los Alimentos (INTA), University of Chile, Santiago 7830489, Chile"},{"name":"Pediatric Neurology Fellowship Program, University of Valpara\u00edso, Valparaiso 2341131, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"ref_1","unstructured":"Centers for Disease Control and  Prevention (2011). Ten Great Public Health Achievements\u2014United States, 2001\u20132010, Morbidity and Mortality Weekly Report (MMWR)."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-319-67144-4_19","article-title":"Newborn Screening: Beyond the Spot","volume":"1031","author":"Urv","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_3","unstructured":"(2020, June 21). Preliminary Overview of the Economies of Latin America and the Caribbean. Available online: https:\/\/repositorio.cepal.org\/bitstream\/handle\/11362\/45001\/129\/S1901096_en.pdf."},{"key":"ref_4","unstructured":"(2020, June 21). World Health Statistics 2020. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/332070\/9789240005105-eng.pdf."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4067\/S0370-41061988000400001","article-title":"Diagn\u00f3stico de Fenilquetonuria en Chile","volume":"59","author":"Colombo","year":"1988","journal-title":"Rev. Chil. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.1007\/s10545-010-9165-8","article-title":"Past, present and future of newborn screening in Chile","volume":"33","author":"Cornejo","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s10545-007-0669-9","article-title":"Newborn screening in Latin America at the beginning of the 21st century","volume":"30","author":"Borrajo","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","article-title":"Current status of newborn screening worldwide: 2015","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin. Perinatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10545-012-9484-z","article-title":"Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2\u2014From screening laboratory results to treatment, follow-up and quality assurance","volume":"35","author":"Burgard","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41591-020-0966-5","article-title":"The role of exome sequencing in newborn screening for inborn errors of metabolism","volume":"26","author":"Adhikari","year":"2020","journal-title":"Nat Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tangeraas, T., S\u00e6ves, I., Klingenberg, C., J\u00f8rgensen, J., Kristensen, E., Gunnarsdottir, G., Hansen, E.V., Strand, J., Lundman, E., and Ferdinandusse, S. (2020). Performance of Expanded Newborn Screening in Norway Supported by Post-Analytical Bioinformatics Tools and Rapid Second-Tier DNA Analyses. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6030051"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Berg, J.S., Agrawal, P.B., Bailey, D.B., Beggs, A.H., Brenner, S.E., Brower, A.M., Cakici, J.A., Ceyhan-Birsoy, O., Chan, K., and Chen, F. (2017). Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics, 139.","DOI":"10.1542\/peds.2016-2252"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-genom-090711-163741","article-title":"Ethical issues with newborn screening in the genomics era","volume":"13","author":"Tarini","year":"2012","journal-title":"Annu Rev. Genomics Hum. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sohn, H., and Timmermans, S. (2019). Inequities in newborn screening: Race and the role of medicaid. SSM Popul. Health, 9.","DOI":"10.1016\/j.ssmph.2019.100496"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/cpt.426","article-title":"History of Orphan Drug Regulation-United States and Beyond","volume":"100","author":"Haffner","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_16","unstructured":"(2020, July 07). Closing the Gap in a Generation: Health Equity Taking Action on the Causes of the Causes, The Commission on Social Determinants of Health Draft. Final Report. December 2007. Available online: https:\/\/www.who.int\/social_determinants\/final_report\/csdh_finalreport_2008.pdf."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/7\/1\/6\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:13:29Z","timestamp":1760159609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/7\/1\/6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["ijns7010006"],"URL":"https:\/\/doi.org\/10.3390\/ijns7010006","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]}}}